Skip to main content
. 2018 May 9;2018(5):CD009069. doi: 10.1002/14651858.CD009069.pub3

2.15. Analysis.

Comparison 2 High‐grade cervical lesions in HPV16/18 DNA negative women at baseline, Outcome 15 Any CIN2+ irrespective of HPV types, 1 or 2 doses (post hoc analysis).